MF-280

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMF-280

Drug Alias Nameanti-CD28 monovalent-Fc antibody (TCL Pharma)anti-CD28 monovalent-Fc antibody (Effimune)MF-280

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionT-cell-specific surface glycoprotein CD28 inhibitors

TargetsT-cell-specific surface glycoprotein CD28

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesEffimune

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesEffimune

Active IndicationsN/A

Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A